• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加速减少伤害干预措施,以应对西太平洋和亚洲的艾滋病毒流行:世界卫生组织(西太平洋区域办事处)的作用。

Accelerating harm reduction interventions to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO (WPRO).

机构信息

World Health Organization, Regional Office for Western Pacific (WPRO), HIV/AIDS and STI Unit, Manila, Philippines.

出版信息

Harm Reduct J. 2008 Aug 5;5:26. doi: 10.1186/1477-7517-5-26.

DOI:10.1186/1477-7517-5-26
PMID:18680604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2546385/
Abstract

The epidemic of HIV/AIDS linked to injecting drug usage is one of the most explosive in recent years. After a historical epicentre in Europe, South and North America, at present it is clearly the main cause of dissemination of the epidemic in Eastern Europe and some key Asian countries. Recently, 10 African countries reported the spread of HIV through people who inject drugs (PWID), breaking one of the final geographical barriers to the globalization of the epidemic of HIV among and from PWID. Several countries of the Asia and Pacific Region have HIV epidemics that are driven by injecting drug usage. Harm reduction interventions have been implemented in many countries and potential barriers to implementation are being overcome. Harm reduction is no longer a marginal approach in the Region; instead, it is the core tool for responding to the HIV/AIDS epidemic among PWID. The development of a comprehensive response in the Region has been remarkable, including scaling up of needle and syringe programmes (NSPs), methadone maintenance treatment (MMT), and care, support and treatment for PWID. This development is being followed up by strong ongoing changes in policies and legislations. The main issue now is to enhance interventions to a level that can impact the epidemic. The World Health Organization (WHO) is one of the leading UN agencies promoting harm reduction. Since the establishment of the Global Programme on AIDS, WHO has been working towards an effective response to the HIV epidemic among PWID. WHO's work is organized into a number of components: establishing an evidence base; advocacy; development of normative standards, tools and guidelines; providing technical support to countries; ensuring access to essential medicines, diagnostics and commodities; and mobilizing resources. In this paper, we trace the course of development of the HIV/AIDS epidemic among and from PWID in the Western Pacific and Asia Region (WPRO) as well as WHO's role in supporting the response in some of the key countries: Cambodia, China, Lao PDR, Malaysia, the Philippines and Viet Nam.

摘要

与注射吸毒有关的艾滋病毒/艾滋病疫情是近年来爆发最迅猛的疫情之一。在欧洲、南美和北美曾出现疫情历史中心之后,目前东欧和一些亚洲关键国家显然是该疫情传播的主要源头。最近,有 10 个非洲国家报告称,艾滋病毒通过注射吸毒者(吸毒者)传播,打破了艾滋病毒在吸毒者中以及从吸毒者向其传播的全球化的最后一个地域障碍。亚太区域有几个国家的艾滋病毒疫情是由注射吸毒驱动的。许多国家已实施减少伤害干预措施,正在克服实施方面的潜在障碍。减少伤害在该区域不再是一种边缘做法;相反,它是应对吸毒者中艾滋病毒疫情的核心工具。该区域的全面应对工作取得了显著进展,包括扩大针具交换方案、美沙酮维持治疗以及对吸毒者的护理、支持和治疗。目前,政策和立法也在持续进行强有力的改革。现在的主要问题是将干预措施提高到能够对疫情产生影响的水平。世界卫生组织(世卫组织)是促进减少伤害的主要联合国机构之一。自全球艾滋病规划成立以来,世卫组织一直致力于对吸毒者中艾滋病毒疫情作出有效应对。世卫组织的工作分为若干组成部分:建立证据基础;宣传;制定规范标准、工具和准则;向各国提供技术支持;确保获得基本药物、诊断试剂和用品;以及调集资源。本文追溯了西太平洋和亚洲区域(西太区)吸毒者中以及来自吸毒者的艾滋病毒/艾滋病疫情的发展轨迹,以及世卫组织在支持柬埔寨、中国、老挝人民民主共和国、马来西亚、菲律宾和越南等一些关键国家应对疫情方面发挥的作用。

相似文献

1
Accelerating harm reduction interventions to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO (WPRO).加速减少伤害干预措施,以应对西太平洋和亚洲的艾滋病毒流行:世界卫生组织(西太平洋区域办事处)的作用。
Harm Reduct J. 2008 Aug 5;5:26. doi: 10.1186/1477-7517-5-26.
2
The long winding road of opioid substitution therapy implementation in South-East Asia: challenges to scale up.东南亚阿片类药物替代疗法实施的漫长曲折之路:扩大规模面临的挑战
J Public Health Res. 2014 Mar 26;3(1):204. doi: 10.4081/jphr.2014.204.
3
Tuberculosis结核病
4
Addressing injecting drug use in Asia and Eastern Europe.解决亚洲和东欧地区的注射吸毒问题。
Curr HIV/AIDS Rep. 2013 Jun;10(2):187-93. doi: 10.1007/s11904-013-0153-0.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs.注射吸毒者预防和治疗艾滋病毒方面的分配效率和实施效率。
Int J Drug Policy. 2016 Dec;38:73-80. doi: 10.1016/j.drugpo.2016.10.011. Epub 2016 Nov 22.
7
Challenge and response: HIV in Asia and the Pacific.挑战与应对:亚太地区的艾滋病毒
Med J Aust. 1996 Nov 4;165(9):489-93. doi: 10.5694/j.1326-5377.1997.tb123234.x.
8
A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011.一项关于1995年至2011年美沙酮维持治疗及针头和注射器项目实施对欧洲艾滋病病毒发病率影响的跨国分析。
Int J Drug Policy. 2016 Jun;32:3-10. doi: 10.1016/j.drugpo.2016.02.007. Epub 2016 Feb 26.
9
What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.2010 - 2012年期间,注射吸毒者在艾滋病毒预防、治疗和护理方面取得了哪些成就?对六个负担最重国家的回顾。
Int J Drug Policy. 2014 Jan;25(1):53-60. doi: 10.1016/j.drugpo.2013.08.004. Epub 2013 Sep 4.
10
The cost-effectiveness of harm reduction.减少伤害的成本效益。
Int J Drug Policy. 2015 Feb;26 Suppl 1:S5-11. doi: 10.1016/j.drugpo.2014.11.007. Epub 2014 Dec 1.

引用本文的文献

1
The Impact of Needle and Syringe Exchange Programs on HIV-Related Risk Behaviors in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis Examining Individual- Versus Community-Level Effects.《在中低收入国家,针具交换项目对与 HIV 相关风险行为的影响:一项系统评价和荟萃分析,分别考察个体和社区层面的效果》。
AIDS Behav. 2023 Oct;27(10):3306-3331. doi: 10.1007/s10461-023-04051-x. Epub 2023 Apr 12.
2
Risk factors of HIV and variation in access to clean needles among people who inject drugs in Pakistan.巴基斯坦注射吸毒者中 HIV 的风险因素和清洁针具获取情况的变化。
Pathog Glob Health. 2023 Dec;117(8):696-707. doi: 10.1080/20477724.2023.2191234. Epub 2023 Mar 22.
3
Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.加拿大境内,符合接受海洛因辅助治疗(HAT)条件的 HIV 合并阿片类药物注射使用人群。
Addict Sci Clin Pract. 2018 Feb 7;13(1):3. doi: 10.1186/s13722-017-0104-y.
4
Barriers and Potential Improvements for Needle and Syringe Exchange Programs (NSPs) in China: A Qualitative Study from Perspectives of Both Health and Public Security Sectors.中国针头和注射器交换项目(NSPs)的障碍与潜在改进措施:一项基于卫生与公安部门视角的定性研究
PLoS One. 2015 Jun 26;10(6):e0130654. doi: 10.1371/journal.pone.0130654. eCollection 2015.
5
Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.马来西亚注射吸毒者对美沙酮和丁丙诺啡维持治疗的治疗准备情况、态度及经历
J Subst Abuse Treat. 2015 Jul;54:29-36. doi: 10.1016/j.jsat.2015.01.014. Epub 2015 Feb 18.
6
Associations between drug use and sexual risks among heterosexual men in the Philippines.菲律宾异性恋男性中药物使用与性风险之间的关联。
Int J STD AIDS. 2013 Dec;24(12):969-76. doi: 10.1177/0956462413490412. Epub 2013 Jul 22.
7
Arguments in favour of compulsory treatment of opioid dependence.支持阿片类药物依赖强制治疗的观点。
Bull World Health Organ. 2013 Feb 1;91(2):142-5. doi: 10.2471/BLT.12.108860.
8
Addressing injecting drug use in Asia and Eastern Europe.解决亚洲和东欧地区的注射吸毒问题。
Curr HIV/AIDS Rep. 2013 Jun;10(2):187-93. doi: 10.1007/s11904-013-0153-0.
9
Harm reduction in Cambodia: a disconnect between policy and practice.柬埔寨的减少伤害措施:政策与实践之间的脱节。
Harm Reduct J. 2012 Jul 9;9:30. doi: 10.1186/1477-7517-9-30.
10
Reaching out and reaching up - developing a low cost drug treatment system in Cambodia.伸出援手——在柬埔寨建立一个低成本的药物治疗系统。
Harm Reduct J. 2012 Mar 12;9:11. doi: 10.1186/1477-7517-9-11.

本文引用的文献

1
Overview of the HIV/AIDS epidemic, scientific research and government responses in China.中国艾滋病疫情概述、科学研究与政府应对措施
AIDS. 2007 Dec;21 Suppl 8:S3-7. doi: 10.1097/01.aids.0000304690.24390.c2.
2
The Chinese free antiretroviral treatment program: challenges and responses.中国免费抗逆转录病毒治疗项目:挑战与应对措施
AIDS. 2007 Dec;21 Suppl 8:S143-8. doi: 10.1097/01.aids.0000304710.10036.2b.
3
Effectiveness of first eight methadone maintenance treatment clinics in China.中国首批八家美沙酮维持治疗门诊的成效
AIDS. 2007 Dec;21 Suppl 8:S103-7. doi: 10.1097/01.aids.0000304704.71917.64.
4
HIV, injecting drug use and harm reduction: a public health response.艾滋病毒、注射吸毒与减少伤害:公共卫生应对措施
Addiction. 2007 May;102(5):684-90. doi: 10.1111/j.1360-0443.2007.01761.x.
5
Five myths about the HIV epidemic in Asia.关于亚洲艾滋病流行的五个误区。
PLoS Med. 2006 Oct;3(10):e426. doi: 10.1371/journal.pmed.0030426.
6
[Analysis for epidemic trend of acquired immunodeficiency syndrome in Yunnan Province of China].[中国云南省获得性免疫缺陷综合征流行趋势分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2004 Sep;38(5):309-12.
7
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.美沙酮维持治疗与无阿片类药物替代治疗对阿片类药物依赖的效果比较
Cochrane Database Syst Rev. 2003(2):CD002209. doi: 10.1002/14651858.CD002209.
8
The Joint United Nations Programme on HIV / AIDS (UNAIDS). Project update.联合国艾滋病规划署(UNAIDS)。项目最新情况。
Pac AIDS Alert Bull. 1999(18):15-6.
9
AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic.1987 - 1993年英国的艾滋病与注射吸毒:政策应对及疫情防控
Soc Sci Med. 1995 Sep;41(5):699-716. doi: 10.1016/0277-9536(94)00435-v.
10
Update on acquired immune deficiency syndrome (AIDS)--United States.美国获得性免疫缺陷综合征(艾滋病)最新情况
MMWR Morb Mortal Wkly Rep. 1982 Sep 24;31(37):507-8, 513-4.